ArticleJournal of cellular and molecular medicine2023

Phosphorylated MAPK11 promotes the progression of clear cell renal cell carcinoma by maintaining RUNX2 protein abundance.

Xiandong Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.